More atherosclerosis seen in those who skip breakfast

9-10-2017 • Uzhova I et al., J Am Coll Cardiol 2017
Skipping breakfast was associated with a higher risk of non-coronary and generalized atherosclerosis in a sample of asymptomatic individuals in thee prospective PESA study. Read more
News • 4-10-2017

Meditation may help CV risk reduction, according to cautiously formulated AHA Scientific Statement

Based on current evidence – mostly of modest methodological quality – AHA concludes that meditation, given its low costs and low risk, may be an adjunct to conventional CV risk reduction approaches. Read more

Discontinuation of long-term aspirin use for CVD prevention associated with higher CV risk

3-10-2017 • Sundström J et al., Circulation. 2017
The discontinuation of low-dose long-term aspirin use for CVD prevention in the absence of major surgery or bleeding, was associated with a >30% increased CV risk, shortly after discontinuation. Read more

Suboptimal adherence to secondary prevention post-MI increases mortality

26-9-2017 • Korhonen MJ et al. J Am Coll Cardiol 2017
Post-AMI patients who are adherent to ACE inhibitors/ARBs and statins, but not to beta-blockers, had a similar mortality risk compared with those adherent to all 3 therapies. Read more
News • 19-9-2017

ESC GRAND DEBATE | Aspirin for life

ESC 2017 One of the ESC Grand Debates revolved around whether or not aspirin should be used for primary and/or secondary CV prevention. Yes, there is a lot of evidence, but how valid is that evidence? Read an impression of the debate. Read more
News • 15-9-2017

Women with diabetes show association between caffeine intake and lower risk of death

EASD 2017 In NHANES data, regularly drinking caffeinated coffee or tea was associated with lower mortality risk in women with diabetes, the protective effect varied with the source of caffeine. Read more

Diabetic patients at high CV risk benefit from intensive BP control

5-10-2017 • Buckley LF et al., Diabetes Care 2017
In a SPRINT-eligible ACCORD-BP population, a high-risk cohort of diabetic patients, intensive BP control at a goal of <120 mmHg, reduced CVD outcomes. Read more

Non-statin LDL-lowering drug plus statin protects against stroke in post-ACS patients

3-10-2017 • Bohula EA et al., Circulation 2017
In the IMPROVE-IT study, the addition of ezetimibe to simvastatin in stabilized post-ACS patients reduced the frequency of ischemic stroke, particularly in patients with a history of prior stroke. Read more

Benefit of physical activity to lower risk of mortality and CVD is seen worldwide

2-10-2017 • Lear SA et al. Lancet 2017
Physical activity is a low-cost approach to reduce deaths and CV disease that is applicable globally with a potential large impact. Read more

Obesity without metabolic abnormalities still associated with increased CV risk

25-9-2017 • Caleyachetty R et al., J Am Coll Cardiol 2017
Individuals previously considered “metabolically healthy obese” are still at higher CV risk compared with normal weight metabolically healthy persons, according to a large UK health record dataset. Read more
News • 16-9-2017

Six instead of three meals per day improves glucose control in obese people with diabetes

EASD 2017 Obese people with prediabetes or diabetes showed better glucose control and were less hungry when taking six meals per day than with three, at an identical level of total calories. Read more
News • 15-9-2017

Cognitive behavioural group therapy does not help prevention weight regain after dieting in T2DM

EASD 2017 Two years after dieting, T2DM patients in a cognitive behavioural group therapy program showed similar weight regain and CV risk factors as those receiving standard care. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...